Dude, someone's got to keep you in check when you're on here spreading total B.S. I'm just amazed that you think the creator of InBev is a dud. Seriously, are you insane ? How many OTC company can walk into Wells Fargo and get a bank loan ... for anything ? Maybe 1 out of 2,000 ? You had the chance to buy at .35 and didn't. You have the chance to buy here and you won't. You'll have the chance again at $3.00 and you'll have yet another lame excuse.
That's what's called for when you're growing at warp speed. And they are laser-focused on giving GT's a run for their money and this will lead to massive shareholder wealth.
Your book is read only by those who want to lose money. You ready for the next accretive acquisition ? LOL. I guarantee you that you'll be warning everyone again at $3.00 and so on.
Another NUWA deal (Tribute Pharmaceuticals - .30 cents when NUWA got involved) was just bought out by Pozen and trades on the Nasdaq as ARLZ. Nice job Kevin, even though I like ABRW 100X better.
He's the full-time CEO of the new company. Dude, you're a continual wealth of misinformation.
You reminded us at .35 cents. How'd that work out for you ? He'll give himself a nice incentive when he acquires a few more businesses. He has no need for money, as the guy's worth well over $100 million. I think it's great he's not raping shareholders. Quite a change for an OTC company, but I doubt it remains an OTC company for long. Anything else you got besides the same rinse and repeat ? Thank God you're not managing anyone's money.
I see you're back as well, so I guess I better set you straight, just as I did back at .35 cents. This Roland Perry guy was given 100K shares ages ago by the old ABRW CEO for stock awareness. This was way back when they were operating the brewery. Roland loves the new CEO, the new business plan and sees where this is headed. He's excited that such a dud company before is now an entirely different company with a CEO that created InBev. As far as NUWA, they're in the microcap space filled with total junk. They love this story and they haven't sold a share, just the same as all other 5% or greater shareholders haven't. NUWA recently did an amazing pre-IPO deal with Rezilient Direct in Austin, TX that has made those that participated an unbelievable return. NUWA has distanced itself from the typical microcap junk and people should be following their every move. Their newest deal is with SFHI and that company looks very promising, although I don't have a stake just yet.
You'll see the SEC filing when the deal closes. It must suck being you, always trying to throw something against the wall, hoping it will stick. You desperately tried at .35 cents to warn everyone. Great work chump.
Looks like I'll have to educate you yet again, as Neil and Julie give up their preferred voting shares after the merger closes. Next ......
I don't drink beer. My specialty is making money.
If you want to keep thinking the total revenue is $14 million that's certainly your choice. Revenue run rate after consummation of the merger will start off at $57.5 million or thereabouts.
Very true and it looks like the total O/S count could be significantly less than 25 million, but I'm using 25 million for all my calculations.
There is NO discrepancy, as the entire New Age portfolio generates over $50 million in revenue annually.
While you're at it, I expect you to turn yourself in to the authorities for attempted stock manipulation.
That's referring to the Xing Tea segment, not the entire portfolio. Entire portfolio is over $50 million plus another $7.5 million (plus). Sheesh.
Peter, you obviously have trouble telling the truth as usual. Kombucha immediately makes its way into 4,500 additional outlets. I'll agree with you that the CEO is a riot, as he just pulled off a move that no other CEO could on the OTC in getting a low interest rate, non-dilutive loan from Wells Fargo. The bank must love the outlook of the company or no way they would have agreed to this deal. Any other B.S. you want to spread ?
Peter, you'd be dangerous with even half a brain, but you're empty upstairs. You're a wealth of misinformation as usual. A bank loan is non-dilutive and a jump from 15 million to 25 million O/S is not a 20-fold increase. At $2.00 a share, the stock would be dirt cheap at 1X sales, but with explosive kombucha growth, a P/S of 2 to 3 is much more likely.